InsiderClue
Insiders · Profile

CAGNONI PABLO J

President, Global Head of R&D at Incyte · Director at CRISPR Therapeutics. Filing since 3 Jul 2018. CIK 0001205703

INCY Incyte President, Global Head of R&D · 8 trades CRSP CRISPR Therapeutics AG Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
INCY Incyte
15 Sep 2026
President, Global Head of R&D
Sold on a plan
23,218
$2.80M
11.2%
INCY Incyte
19 Aug 2026
President, Global Head of R&D
Sold on a plan
10,801
$1.36M
5.6%
INCY Incyte
12 Aug 2026
President, Global Head of R&D
Sold on a plan
10,803
$1.30M
5.3%
INCY Incyte
5 Aug 2026
President, Global Head of R&D
Sold on a plan
10,640
$1.31M
4.9%
INCY Incyte
31 Jul 2026
President, Global Head of R&D
Sold on a plan
15,888
$1.90M
6.9%
INCY Incyte
17 Apr 2026
President, Global Head of R&D
Sold on a plan
18,667
$1.80M
6.6%
INCY Incyte
17 Mar 2026
President, R&D
Sold on a plan
18,667
$1.76M
7.4%
INCY Incyte
19 Feb 2026
President, R&D
Sold on a plan
18,668
$1.88M
7.4%
CRSP CRISPR Therapeutics AG
19 Nov 2019
Director
Sold, plan not stated
7,500
$465.00K
100%
CRSP CRISPR Therapeutics AG
12 Nov 2019
Director
Sold, plan not stated
7,500
$412.50K
100%
CRSP CRISPR Therapeutics AG
30 Oct 2019
Director
Sold, plan not stated
7,500
$390.00K
100%
CRSP CRISPR Therapeutics AG
5 Jul 2018
Director
Sold, plan not stated
1,684
$104.41K
100%
CRSP CRISPR Therapeutics AG
3 Jul 2018
Director
Sold, plan not stated
5,816
$360.59K
100%
13 decisions on file.